Similar articles

• Phenobarbital and neonatal jaundice. The need for more knowledge.

  Sisson TR. Sisson TR. Clin Pediatr (Phila). 1971 Dec;10(12):683-4. doi: 10.1177/000992287101001201. Clin Pediatr (Phila). 1971. PMID: 4334543 No abstract available.
• Phenobarbital in the perinatal period.

  Wilson JT. Wilson JT. Pediatrics. 1969 Mar;43(3):324-7. Pediatrics. 1969. PMID: 4886955 Review. No abstract available.
• Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment.

  Trolle D. Trolle D. Lancet. 1968 Sep 28;2(7570):705-8. doi: 10.1016/s0140-6736(68)90750-2. Lancet. 1968. PMID: 4175089 No abstract available.
• [The pros and cons of luminal teatment of hyperbilirubinemia].

  Lüders D. Lüders D. Monatsschr Kinderheilkd (1902). 1970 Mar;118(3):94-102. Monatsschr Kinderheilkd (1902). 1970. PMID: 4333560 Review. German. No abstract available.
• Phenobarbitone prophylaxis for neonatal hyperbilirubinemia.

  Yeung CY, Tam LS, Chan A, Lee KH. Yeung CY, et al. Pediatrics. 1971 Sep;48(3):372-6. Pediatrics. 1971. PMID: 5094338 No abstract available.